Report Scope & Overview:
IVD Antibody Market is expected to grow at a CAGR of 3.8% during the forecast period from 2022 to 2030. And is slated to reach US$ 1,842.8 Mn by 2030, rising from US$ 1,368.2 Mn in 2022.
Global IVD Antibody Market research provides insights into consumer behavior, industry trends, and market competition through the use of various research techniques, including surveys, interviews, and data analysis. The industry serves a wide range of clients, including businesses, government agencies, and non-profit organizations. IVD Antibody Market is highly diverse, with a range of services and specialties, including quantitative and qualitative research, brand research, product testing, customer satisfaction research, and competitive analysis.
IVD Antibody Market Key Trends
COVID-19 Pandemic Impact: The COVID-19 pandemic has significantly influenced the IVD antibody market. Rapid development and deployment of serological tests, including antibody tests for COVID-19, have been a major trend. Continuous advancements and adaptations to address the evolving challenges of the pandemic are noteworthy.
Rise of Personalized Medicine: The trend towards personalized medicine involves tailoring medical treatment to the individual characteristics of each patient. IVD antibodies are essential tools for identifying specific biomarkers that help guide personalized treatment plans.
Advancements in Monoclonal Antibody Technologies: Advances in monoclonal antibody technologies have led to the development of more specific and targeted antibodies for diagnostic purposes. This includes the use of recombinant antibodies and other innovative platforms that enhance sensitivity and specificity in diagnostic assays.
Multiplex Testing: The trend toward multiplex testing involves the simultaneous detection of multiple analytes in a single test. IVD antibodies are used in multiplex assays for diagnosing complex conditions and gaining a more comprehensive understanding of a patient's health.
Market Segmentations:Global IVD Antibody Market: By Company
• BD PharMingen
• Abcam
• R&D Systems
• Cell Signaling Technology
• Affymatrix
• BioLegend
• Santa Cruz Biotechnologies
• Beckman Coulter
• Roche/Ventana
Global IVD Antibody Market: By Type
• mAb
• pAb
• rAbs
Global IVD Antibody Market: By Application
• RIA
• ELISA
• CLIA
• LFIA
• Other
Global IVD Antibody Market: Regional Analysis
All the regional segmentation has been studied based on recent and future trends, and the market is forecasted throughout the prediction period. The countries covered in the regional analysis of the Global IVD Antibody market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America.
| Report Attribute/Metric | Details |
| Market Size 2022 | US$ 1,368.2 Mn |
| Market Size 2030 | US$ 1,842.8 Mn |
| Compound Annual Growth Rate (CAGR) | 3.8%(2023-2030) |
| Base Year | 2022 |
| Forecast Period | 2023-2032 |
| Historical Data | 2018-2022 |
| Forecast Units | Value (US$ Mn ) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| By Type | • mAb • pAb • rAbs |
| By Application | • RIA • ELISA • CLIA • LFIA |
| Key Companies Profiled | • BD PharMingen • Abcam • R&D Systems • Cell Signaling Technology • Affymatrix • BioLegend • Santa Cruz Biotechnologies • Beckman Coulter • Roche/Ventana |
| Regions and Key Countries Covered | U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America |
| Customization Scope | Available on Request |
Reasons to Purchase IVD Antibody Market Report:
• To gain insights into market trends and dynamics: this reports provide valuable insights into industry trends and dynamics, including market size, growth rates, and key drivers and challenges.
• To identify key players and competitors: this research reports can help businesses identify key players and competitors in their industry, including their market share, strategies, and strengths and weaknesses.
• To understand consumer behavior: this research reports can provide valuable insights into consumer behavior, including their preferences, purchasing habits, and demographics.
• To evaluate market opportunities: this research reports can help businesses evaluate market opportunities, including potential new products or services, new markets, and emerging trends.
• To make informed business decisions: this research reports provide businesses with data-driven insights that can help them make informed business decisions, including strategic planning, product development, and marketing and advertising strategies
Objectives of IVD Antibody Market Study:
The objectives of IVD Antibody market research report may vary depending on the specific needs and goals of the business or organization commissioning the report. However, some common objectives of market research reports include:
• Understanding the market size and potential: One of the primary objectives of IVD Antibody market research is to understand the size and potential of a particular market. This includes analyzing market trends and dynamics, identifying key players and competitors, and assessing the demand for products or services.
• Identifying target customers and segments: this market research reports can help businesses identify and understand their target customers and market segments, including their preferences, behaviors, and demographics. This information can be used to develop targeted marketing and advertising strategies.
• Evaluating product or service performance: this market research reports can provide valuable insights into the performance of products or services, including customer satisfaction, product usage, and product quality. This information can be used to improve products or services and enhance customer satisfaction.
• Assessing market opportunities and threats: this market research reports can help businesses identify potential market opportunities and threats, including emerging trends, competitive threats, and new market entrants. This information can be used to develop strategic plans and make informed business decisions.
• Developing effective marketing and advertising strategies: this market research reports can help businesses develop effective marketing and advertising strategies by providing insights into customer preferences and behavior, competitive dynamics, and market trends. This can help businesses improve brand awareness, customer engagement, and overall marketing effectiveness.
Frequently Asked Questions
IVD Antibody Market is expected to grow at a CAGR of 3.8% during the forecast period from 2022 to 2030. And is slated to reach US$ 1,842.8 Mn by 2030, rising from US$ 1,368.2 Mn in 2022.
All the regional segmentation has been studied based on recent and future trends, and the market is forecasted throughout the prediction period. The countries covered in the regional analysis of the Global IVD Antibody market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America.
The major players in the market include BD PharMingen, Abcam, R&D Systems,Cell Signaling Technology, Affymatrix, BioLegend, Santa Cruz Biotechnologies, Beckman Coulter, Roche/Ventana
The market is driven by increasing demand for personalized medicine, rising prevalence of infectious diseases, and advancements in diagnostic technologies.
Monoclonal antibodies play a crucial role in IVD by enabling highly specific and sensitive detection of biomarkers, contributing to accurate diagnostics.
TABLE OF CONTENT
1.1 Product Overview and Scope of IVD Antibody
1.2 IVD Antibody Segment by Type
1.2.1 Global IVD Antibody Market Value Comparison by Type (2023-2032)
1.2.2 mAb
1.2.3 pAb
1.2.4 rAbs
1.3 IVD Antibody Segment by Application
1.3.1 Global IVD Antibody Market Value by Application: (2023-2032)
1.3.2 RIA
1.3.3 ELISA
1.3.4 CLIA
1.3.5 LFIA
1.3.6 Other
1.4 Global IVD Antibody Market Size Estimates and Forecasts
1.4.1 Global IVD Antibody Revenue 2017-2032
1.4.2 Global IVD Antibody Sales 2017-2032
1.4.3 Global IVD Antibody Market Average Price (2017-2032)
1.5 Assumptions and Limitations
2 IVD Antibody Market Competition by Manufacturers
2.1 Global IVD Antibody Sales Market Share by Manufacturers (2017-2023)
2.2 Global IVD Antibody Revenue Market Share by Manufacturers (2017-2023)
2.3 Global IVD Antibody Average Price by Manufacturers (2017-2023)
2.4 Global IVD Antibody Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of IVD Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of IVD Antibody, Product Type & Application
2.7 IVD Antibody Market Competitive Situation and Trends
2.7.1 IVD Antibody Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest IVD Antibody Players Market Share by Revenue
2.7.3 Global IVD Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 IVD Antibody Retrospective Market Scenario by Region
3.1 Global IVD Antibody Market Size by Region: 2017 Versus 2022 Versus 2032
3.2 Global IVD Antibody Global IVD Antibody Sales by Region: 2017-2032
3.2.1 Global IVD Antibody Sales by Region: 2017-2023
3.2.2 Global IVD Antibody Sales by Region: 2023-2032
3.3 Global IVD Antibody Global IVD Antibody Revenue by Region: 2017-2032
3.3.1 Global IVD Antibody Revenue by Region: 2017-2023
3.3.2 Global IVD Antibody Revenue by Region: 2023-2032
3.4 North America IVD Antibody Market Facts & Figures by Country
3.4.1 North America IVD Antibody Market Size by Country: 2017 VS 2022 VS 2032
3.4.2 North America IVD Antibody Sales by Country (2017-2032)
3.4.3 North America IVD Antibody Revenue by Country (2017-2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe IVD Antibody Market Facts & Figures by Country
3.5.1 Europe IVD Antibody Market Size by Country: 2017 VS 2022 VS 2032
3.5.2 Europe IVD Antibody Sales by Country (2017-2032)
3.5.3 Europe IVD Antibody Revenue by Country (2017-2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific IVD Antibody Market Facts & Figures by Country
3.6.1 Asia Pacific IVD Antibody Market Size by Country: 2017 VS 2022 VS 2032
3.6.2 Asia Pacific IVD Antibody Sales by Country (2017-2032)
3.6.3 Asia Pacific IVD Antibody Revenue by Country (2017-2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America IVD Antibody Market Facts & Figures by Country
3.7.1 Latin America IVD Antibody Market Size by Country: 2017 VS 2022 VS 2032
3.7.2 Latin America IVD Antibody Sales by Country (2017-2032)
3.7.3 Latin America IVD Antibody Revenue by Country (2017-2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa IVD Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa IVD Antibody Market Size by Country: 2017 VS 2022 VS 2032
3.8.2 Middle East and Africa IVD Antibody Sales by Country (2017-2032)
3.8.3 Middle East and Africa IVD Antibody Revenue by Country (2017-2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global IVD Antibody Sales by Type (2017-2032)
4.1.1 Global IVD Antibody Sales by Type (2017-2023)
4.1.2 Global IVD Antibody Sales by Type (2023-2032)
4.1.3 Global IVD Antibody Sales Market Share by Type (2017-2032)
4.2 Global IVD Antibody Revenue by Type (2017-2032)
4.2.1 Global IVD Antibody Revenue by Type (2017-2023)
4.2.2 Global IVD Antibody Revenue by Type (2023-2032)
4.2.3 Global IVD Antibody Revenue Market Share by Type (2017-2032)
4.3 Global IVD Antibody Price by Type (2017-2032)
5 Segment by Application
5.1 Global IVD Antibody Sales by Application (2017-2032)
5.1.1 Global IVD Antibody Sales by Application (2017-2023)
5.1.2 Global IVD Antibody Sales by Application (2023-2032)
5.1.3 Global IVD Antibody Sales Market Share by Application (2017-2032)
5.2 Global IVD Antibody Revenue by Application (2017-2032)
5.2.1 Global IVD Antibody Revenue by Application (2017-2023)
5.2.2 Global IVD Antibody Revenue by Application (2023-2032)
5.2.3 Global IVD Antibody Revenue Market Share by Application (2017-2032)
5.3 Global IVD Antibody Price by Application (2017-2032)
6 Key Companies Profiled
6.1 BD PharMingen
6.1.1 BD PharMingen Corporation Information
6.1.2 BD PharMingen Description and Business Overview
6.1.3 BD PharMingen IVD Antibody Sales, Revenue and Gross Margin (2017-2023)
6.1.4 BD PharMingen IVD Antibody Product Portfolio
6.1.5 BD PharMingen Recent Developments/Updates
6.2 Abcam
6.2.1 Abcam Corporation Information
6.2.2 Abcam Description and Business Overview
6.2.3 Abcam IVD Antibody Sales, Revenue and Gross Margin (2017-2023)
6.2.4 Abcam IVD Antibody Product Portfolio
6.2.5 Abcam Recent Developments/Updates
6.3 R&D Systems
6.3.1 R&D Systems Corporation Information
6.3.2 R&D Systems Description and Business Overview
6.3.3 R&D Systems IVD Antibody Sales, Revenue and Gross Margin (2017-2023)
6.3.4 R&D Systems IVD Antibody Product Portfolio
6.3.5 R&D Systems Recent Developments/Updates
6.4 Cell Signaling Technology
6.4.1 Cell Signaling Technology Corporation Information
6.4.2 Cell Signaling Technology Description and Business Overview
6.4.3 Cell Signaling Technology IVD Antibody Sales, Revenue and Gross Margin (2017-2023)
6.4.4 Cell Signaling Technology IVD Antibody Product Portfolio
6.4.5 Cell Signaling Technology Recent Developments/Updates
6.5 Affymatrix
6.5.1 Affymatrix Corporation Information
6.5.2 Affymatrix Description and Business Overview
6.5.3 Affymatrix IVD Antibody Sales, Revenue and Gross Margin (2017-2023)
6.5.4 Affymatrix IVD Antibody Product Portfolio
6.5.5 Affymatrix Recent Developments/Updates
6.6 BioLegend
6.6.1 BioLegend Corporation Information
6.6.2 BioLegend Description and Business Overview
6.6.3 BioLegend IVD Antibody Sales, Revenue and Gross Margin (2017-2023)
6.6.4 BioLegend IVD Antibody Product Portfolio
6.6.5 BioLegend Recent Developments/Updates
6.7 Santa Cruz Biotechnologies
6.6.1 Santa Cruz Biotechnologies Corporation Information
6.6.2 Santa Cruz Biotechnologies Description and Business Overview
6.6.3 Santa Cruz Biotechnologies IVD Antibody Sales, Revenue and Gross Margin (2017-2023)
6.4.4 Santa Cruz Biotechnologies IVD Antibody Product Portfolio
6.7.5 Santa Cruz Biotechnologies Recent Developments/Updates
6.8 Beckman Coulter
6.8.1 Beckman Coulter Corporation Information
6.8.2 Beckman Coulter Description and Business Overview
6.8.3 Beckman Coulter IVD Antibody Sales, Revenue and Gross Margin (2017-2023)
6.8.4 Beckman Coulter IVD Antibody Product Portfolio
6.8.5 Beckman Coulter Recent Developments/Updates
6.9 Roche/Ventana
6.9.1 Roche/Ventana Corporation Information
6.9.2 Roche/Ventana Description and Business Overview
6.9.3 Roche/Ventana IVD Antibody Sales, Revenue and Gross Margin (2017-2023)
6.9.4 Roche/Ventana IVD Antibody Product Portfolio
6.9.5 Roche/Ventana Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 IVD Antibody Industry Chain Analysis
7.2 IVD Antibody Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 IVD Antibody Production Mode & Process
7.4 IVD Antibody Sales and Marketing
7.4.1 IVD Antibody Sales Channels
7.4.2 IVD Antibody Distributors
7.5 IVD Antibody Customers
8 IVD Antibody Market Dynamics
8.1 IVD Antibody Industry Trends
8.2 IVD Antibody Market Drivers
8.3 IVD Antibody Market Challenges
8.4 IVD Antibody Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Abcam
R&D Systems
Cell Signaling Technology
Affymatrix
BioLegend
Santa Cruz Biotechnologies
Beckman Coulter
Roche/Ventana
In Vitro Diagnostics Quality Control Market
Global In Vitro Diagnostics Quality Control Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast
Ileostomy Market
Global Ileostomy Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast
Hypertrophic Cardiomyopathy (HCM) Therapeutics Market
Global Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast
Human Papillomavirus Vaccine Market
Global Human Papillomavirus Vaccine Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast
Hospital Acquired Pneumonia Drugs Market
Global Hospital Acquired Pneumonia Drugs Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast